Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 163

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 163
---
 issued
warrants to purchase 16,666 Ordinary Shares to a certain institutional investor at an exercise price of £2.70 per share.

On February 15, 2023, we completed the closing of a private placement pursuant to which we sold to certain institutional investors (1) 3,250,000 Ordinary Shares represented by 32 Depositary Shares at $46,400.00 per Depositary Share, (2) 12,931,020 Ordinary Shares represented by 129 Depositary Shares, issuable upon the exercise of Series A Warrants issued in the private placement at an exercise price of $53,600.00 per warrant, (3) 19,396,400 Ordinary Shares represented by 193 Depositary Shares, issuable upon the exercise of Series B Warrants issued in the private placement at an exercise price of $53,600.00 per warrant, and (4) 62,184,525 Ordinary Shares represented by 621 Depositary Shares, issuable upon the exercise of pre-funded warrants issued in the private placement at an exercise price of $8.00 per warrant, for aggregate gross proceeds of approximately $6.0 million. We also issued unregistered placement agent warrants to purchase a total of 500,000 Ordinary Shares represented by five Depositary Shares toLadenburg Thalmann & Co. Inc., or Ladenburg, at an exercise price of $58,000.00 per warrant, and Series A Warrants to purchase 625,000 Ordinary Shares represented by Depositary Shares at an exercise price of $53,600.00 per warrant to an investor pursuant to a waiver.

| II-1 |

On May 26, 2023, in a private
placement with certain institutional investors, we sold (1) 166,017,700 Ordinary Shares represented by 1,660 Depositary Shares, issuable
upon the exercise of the Series C Warrants at an exercise price of $4,000.00 per warrant, (2) 110,675,600 Ordinary Shares represented
1,098 Depositary Shares issuable upon the exercise of the Series D Warrants at an exercise price of $4,000.00 per warrant and, (3) 4,426,800
Ordinary Shares represented by 44 Depositary Shares issuable upon the exercise of the May 2023 Placement Agent Warrants at an exercise
price of $3,750.00 per warrant.

On December 21, 2023, in two